Most decisions to reject or roll out drugs on NHS backed by poor evidence, study suggests
Two thirds of decisions to reject or roll out drugs on the NHS are backed by poor clinical evidence, a study suggests.
Source: yahoo.com
Stay updated with breaking news from Jacoline Bouvy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Two thirds of decisions to reject or roll out drugs on the NHS are backed by poor clinical evidence, a study suggests.